Open AccessComparative study between propofol and dexmedetomidine for conscious sedation in patients undergoing outpatient colonoscopy
Author(s) -
Harish Karanth,
Sumesh Murali,
Reshma Koteshwar,
Vasanth Shetty,
Karunakara K. Adappa
Publication year - 2018
Publication title -
al-banǧ. maqālāt wa abḥāṯ fī al-taẖdīr wa-al-in’āš
Language(s) - English
Resource type - Journals
ISSN - 0259-1162
DOI - 10.4103/aer.aer_206_17
Subject(s) - dexmedetomidine , sedation , medicine , propofol , anesthesia , colonoscopy , sedative , analgesic , adverse effect , colorectal cancer , cancer
Colonoscopy is a mildly painful procedure requiring conscious sedation. Though propofol is a widely used anesthetic agent in day-care procedures due to its rapid onset and quick recovery has a drawback of requiring resuscitation maneuvers more often than the conventional methods. Dexmedetomidine, a newly introduced, highly selective α 2 -adrenergic receptor agonist possessing hypnotic, sedative, anxiolytic, sympatholytic, and analgesic properties with impressive safety margin, needs to be explored for use in conscious sedation for colonoscopy procedure among South Indian population.